SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-014239
Filing Date
2024-01-24
Accepted
2024-01-24 16:17:00
Documents
13
Period of Report
2024-01-24
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d74405d8k.htm   iXBRL 8-K 47218
2 EX-2.2 d74405dex22.htm EX-2.2 96732
  Complete submission text file 0001193125-24-014239.txt   298049

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ortx-20240124.xsd EX-101.SCH 2518
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20240124_lab.xml EX-101.LAB 17787
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20240124_pre.xml EX-101.PRE 11183
7 EXTRACTED XBRL INSTANCE DOCUMENT d74405d8k_htm.xml XML 3663
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 24556649
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)